222 related articles for article (PubMed ID: 11802798)
1. Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.
Müller O; Schalla C; Scheibner J; Stange EF; Fuchs M
Biochem J; 2002 Feb; 361(Pt 3):673-9. PubMed ID: 11802798
[TBL] [Abstract][Full Text] [Related]
2. Hepatic canalicular membrane transport of bile salt in C57L/J and AKR/J mice: implications for cholesterol gallstone formation.
Hoda F; Green RM
J Membr Biol; 2003 Nov; 196(1):9-14. PubMed ID: 14724752
[TBL] [Abstract][Full Text] [Related]
3. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
Xu G; Zhao L; Fuchs M
Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
[TBL] [Abstract][Full Text] [Related]
4. Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice.
Wang HH; Lammert F; Schmitz A; Wang DQ
Eur J Clin Invest; 2010 Jun; 40(6):541-51. PubMed ID: 20456485
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology Of biliary lipid secretion.
Wang DQ; Lammert F; Paigen B; Carey MC
J Lipid Res; 1999 Nov; 40(11):2066-79. PubMed ID: 10553010
[TBL] [Abstract][Full Text] [Related]
6. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.
Fuchs M; Ivandic B; Müller O; Schalla C; Scheibner J; Bartsch P; Stange EF
Hepatology; 2001 Jun; 33(6):1451-9. PubMed ID: 11391534
[TBL] [Abstract][Full Text] [Related]
7. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocyte bile salt transporters in cholesterol gallstone-susceptible and resistant inbred mouse strains.
Liu JJ; Glickman JN; Masyuk AI; Larusso NF
J Gastroenterol Hepatol; 2008 Oct; 23(10):1596-602. PubMed ID: 18717763
[TBL] [Abstract][Full Text] [Related]
9. Identification of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Madin-Darby canine kidney cells.
Ortiz DF; Moseley J; Calderon G; Swift AL; Li S; Arias IM
J Biol Chem; 2004 Jul; 279(31):32761-70. PubMed ID: 15159385
[TBL] [Abstract][Full Text] [Related]
10. Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice.
Fuchs M; Lammert F; Wang DQ; Paigen B; Carey MC; Cohen DE
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):33-7. PubMed ID: 9806881
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of interaction of BSEP and HAX-1 on the canalicular membrane of hepatocytes in a mouse model of cholesterol cholelithiasis.
Kong J; Liu BB; Wu SD; Wang Y; Jiang QQ; Guo EL
Int J Clin Exp Pathol; 2014; 7(4):1644-50. PubMed ID: 24817961
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.
Clarke GA; Bouchard G; Paigen B; Carey MC
Gut; 2004 Jan; 53(1):136-42. PubMed ID: 14684588
[TBL] [Abstract][Full Text] [Related]
13. Mice overexpressing hepatic Abcb11 rapidly develop cholesterol gallstones.
Henkel A; Wei Z; Cohen DE; Green RM
Mamm Genome; 2005 Dec; 16(12):903-8. PubMed ID: 16341669
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism.
Fuchs M; Hafer A; Münch C; Kannenberg F; Teichmann S; Scheibner J; Stange EF; Seedorf U
J Biol Chem; 2001 Dec; 276(51):48058-65. PubMed ID: 11673458
[TBL] [Abstract][Full Text] [Related]
15. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis.
Figge A; Lammert F; Paigen B; Henkel A; Matern S; Korstanje R; Shneider BL; Chen F; Stoltenberg E; Spatz K; Hoda F; Cohen DE; Green RM
J Biol Chem; 2004 Jan; 279(4):2790-9. PubMed ID: 14570929
[TBL] [Abstract][Full Text] [Related]
16. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
[TBL] [Abstract][Full Text] [Related]
17. Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.
Voshol PJ; Koopen NR; de Vree JM; Havinga R; Princen HM; Elferink RP; Groen AK; Kuipers F
J Hepatol; 2001 Feb; 34(2):202-9. PubMed ID: 11281547
[TBL] [Abstract][Full Text] [Related]
18. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport.
Beukeveld GJ; In 't Veld G; Havinga R; Groen AK; Wolthers BG; Kuipers F
J Hepatol; 1996 Mar; 24(3):343-52. PubMed ID: 8778203
[TBL] [Abstract][Full Text] [Related]
19. Aging per se is an independent risk factor for cholesterol gallstone formation in gallstone susceptible mice.
Wang DQ
J Lipid Res; 2002 Nov; 43(11):1950-9. PubMed ID: 12401894
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats.
Vos TA; Ros JE; Havinga R; Moshage H; Kuipers F; Jansen PL; Müller M
Hepatology; 1999 Jun; 29(6):1833-9. PubMed ID: 10347127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
